It is a pharma private limited company based in Delhi, Delhi, India, established in 2007.
2007 | Delhi, Delhi, India | ActiveLederle Pharma Private Limited, a active private limited company, was established on 14 September 2007 in Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U24233DL2007PLC168221. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.50 Cr and a paid-up capital of ₹1.25 Cr.
Formerly known as Lederle Pharma Private Limited. It upholds a compliant status. Its leadership includes Mehul Surana (Director), Ajay Kumar Surana (Director), Sanjay Surana (Director). Past directors included Ajay Kumar Surana, Deepanjay Jain, Urmila Surana. It holds ₹1.25 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at A-75, Second Floor, Block - A Kirti Nagar, Delhi, Delhi, Delhi, 110015.
U24233DL2007PTC168221
168221
14 September 2007
₹1.50 Cr
₹1.25 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Lederle Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mehul Surana | Director | 12 Jul 2021 | Current |
| Ajay Kumar Surana | Director | 01 Jul 2017 | Current |
| Sanjay Surana | Director | 26 Oct 2007 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
| Pramod Abcsdd | Director | 13 Sep 2021 | Past |
| Pramod Abcsdd | Additional Director | 09 Apr 2018 | Past |
| Pramod Abcsdd | Managing Director | 01 Apr 2015 | Past |
| Pramod Abcsdd | Additional Director | 01 Apr 2015 | Past |
| Pramod Abcsdd | Director | 02 Feb 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Lederle Pharma Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 34.26% increase. The company also saw a substantial improvement in profitability, with a 115.56% increase in profit. The company's net worth moved up by a moderate rise of 0.5%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Lederle Pharma had a promoter holding of 35.18% and a public holding of 64.82%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹12,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Jun 2010 | The Nainital Bank Limited | ₹1.25 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Lederle Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Lederle Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lederle Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Lederle Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Lederle Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
Progress on Mehul Surana was appointed as a Director was appointed as a Director on 12 Jul 2021 & has been associated with this company since 4 years 4 months . was documented.
The activity Ajay Kumar Surana was appointed as a Director was appointed as a Director on 01 Jul 2017 & has been associated with this company since 8 years 5 months . was completed.
Progress on A charge with The Nainital Bank Limited amounted to Rs. 1.25 Cr with Charge ID 10225664 was registered on 14 Jun 2010. was documented.
The activity Sanjay Surana was appointed as a Director was appointed as a Director on 26 Oct 2007 & has been associated with this company since 18 years 1 month . was completed.
The CIN of Lederle Pharma Private Limited is U24233DL2007PTC168221.
Lederle Pharma Private Limited is headquartered at A-75, Second Floor, Block - A Kirti Nagar, Delhi, Delhi, Delhi, 110015.
Lederle Pharma Private Limited was incorporated on 14 September 2007.
The current directors of Lederle Pharma Private Limited are
The primary industry of Lederle Pharma Private Limited is Manufacturing.
Lederle Pharma Private Limited is unlisted.
The authorized capital of Lederle Pharma Private Limited is ₹1.50 Cr, and the paid-up capital is ₹1.25 Cr.
The compliance status of Lederle Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX